ArticleFrontiers in genetics2026

Metabolic programs associated with GDSC2-inferred oxaliplatin sensitivity are favorably prognostic in gastric cancer: transcriptomic and single-cell evidence.

Lingyun Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.